Notably, for B-ALL patients lacking prognosis-defining genetic aberrations, CD123 was identified as an independent favorable prognostic factor for EFS and RFS, thus providing a valuable marker for outcome prediction in these patients. Here, IL3RA is linked to acute lymphoblastic leukemia.